{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T00:30:34Z","timestamp":1722731434597},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,21]]},"DOI":"10.7759\/cureus.25194","type":"journal-article","created":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T03:13:13Z","timestamp":1653189193000},"source":"Crossref","is-referenced-by-count":0,"title":["Primary Systemic Amyloidosis With Cardiac and Renal Involvement"],"prefix":"10.7759","author":[{"given":"Shin Ying","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen Shen","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatin Izni","family":"Nazri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisya Natasya","family":"Musa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd Arif","family":"Mohd Zim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2017.03.032","article-title":"Triglyceride to high-density lipoprotein cholesterol ratio and cardiovascular events in diabetics with coronary artery disease","volume":"354","author":"Yang SH","year":"2017","unstructured":"Yang SH, Du Y, Li XL, et al.. Triglyceride to high-density lipoprotein cholesterol ratio and cardiovascular events in diabetics with coronary artery disease. Am J Med Sci. 2017, 354:117-24. 10.1016\/j.amjms.2017.03.032","journal-title":"Am J Med Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000091183.93122.c7","article-title":"Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients","volume":"82","author":"Park MA","year":"2003","unstructured":"Park MA, Mueller PS, Kyle RA, Larson DR, Plevak MF, Gertz MA. Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients. Medicine (Baltimore). 2003, 82:291-8. 10.1097\/01.md.0000091183.93122.c7","journal-title":"Medicine (Baltimore)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1378\/chest.98.1.20","article-title":"Amyloidosis and pleural disease","volume":"98","author":"Kavuru MS","year":"1990","unstructured":"Kavuru MS, Adamo JP, Ahmad M, Mehta AC, Gephardt GN. Amyloidosis and pleural disease. Chest. 1990, 98:20-3. 10.1378\/chest.98.1.20","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcp.0000162378.35928.37","article-title":"Pleural effusions in systemic amyloidosis","volume":"11","author":"Berk JL","year":"2005","unstructured":"Berk JL. Pleural effusions in systemic amyloidosis. Curr Opin Pulm Med. 2005, 11:324-8. 10.1097\/01.mcp.0000162378.35928.37","journal-title":"Curr Opin Pulm Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2013.06.051","article-title":"Cardiac amyloidosis: updates in diagnosis and management","volume":"106","author":"Mohty D","year":"2013","unstructured":"Mohty D, Damy T, Cosnay P, Echahidi N, Casset-Senon D, Virot P, Jaccard A. Cardiac amyloidosis: updates in diagnosis and management. Arch Cardiovasc Dis. 2013, 106:528-40. 10.1016\/j.acvd.2013.06.051","journal-title":"Arch Cardiovasc Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/echo.14952","article-title":"Echocardiographic diagnosis of cardiac amyloidosis: does the masquerader require only a \"cherry on top\"?","volume":"37","author":"Kiotsekoglou A","year":"2020","unstructured":"Kiotsekoglou A, Saha SK, Nanda NC, Lindqvist P. Echocardiographic diagnosis of cardiac amyloidosis: does the masquerader require only a \"cherry on top\"?. Echocardiography. 2020, 37:1713-5. 10.1111\/echo.14952","journal-title":"Echocardiography"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0b013e3181bdba8f","article-title":"Cardiac amyloidosis: approaches to diagnosis and management","volume":"18","author":"Desai HV","year":"2010","unstructured":"Desai HV, Aronow WS, Peterson SJ, Frishman WH. Cardiac amyloidosis: approaches to diagnosis and management. Cardiol Rev. 2010, 18:1-11. 10.1097\/CRD.0b013e3181bdba8f","journal-title":"Cardiol Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00455-020-10160-9","article-title":"Diagnosis of unusual case of dysphagia with macroglossia and rigid tongue","volume":"36","author":"Ryu H","year":"2021","unstructured":"Ryu H, Kim SH, Park JS, et al.. Diagnosis of unusual case of dysphagia with macroglossia and rigid tongue. Dysphagia. 2021, 36:500-2. 10.1007\/s00455-020-10160-9","journal-title":"Dysphagia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2020.08.004","article-title":"Systemic amyloidosis caused by monoclonal immunoglobulins: soft tissue and vascular involvement","volume":"34","author":"Hoffman JE","year":"2020","unstructured":"Hoffman JE, Dempsey NG, Sanchorawala V. Systemic amyloidosis caused by monoclonal immunoglobulins: soft tissue and vascular involvement. Hematol Oncol Clin North Am. 2020, 34:1099-113. 10.1016\/j.hoc.2020.08.004","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000444287","article-title":"The clinical presentation and management of systemic light-chain amyloidosis in China","volume":"2","author":"Huang XH","year":"2016","unstructured":"Huang XH, Liu ZH. The clinical presentation and management of systemic light-chain amyloidosis in China. Kidney Dis (Basel). 2016, 2:1-9. 10.1159\/000444287","journal-title":"Kidney Dis (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.725","article-title":"Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis","volume":"5","author":"Lisenko K","year":"2016","unstructured":"Lisenko K, Sch\u00f6nland SO, Jauch A, et al.. Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis. Cancer Med. 2016, 5:1464-72. 10.1002\/cam4.725","journal-title":"Cancer Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703200","article-title":"An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis","volume":"28","author":"Sanchorawala V","year":"2001","unstructured":"Sanchorawala V, Wright DG, Seldin DC, et al.. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Bone Marrow Transplant. 2001, 28:637-42. 10.1038\/sj.bmt.1703200","journal-title":"Bone Marrow Transplant"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/97480-primary-systemic-amyloidosis-with-cardiac-and-renal-involvement","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:27Z","timestamp":1707507807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/97480-primary-systemic-amyloidosis-with-cardiac-and-renal-involvement"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,21]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.25194","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,21]]}}}